Cargando…

Prognostic factors in patients after definitive chemoradiation using involved‐field radiotherapy for esophageal cancer in a phase II study

BACKGROUND: A prospective study was performed on the use of chemoradiotherapy (CRT) for esophageal cancer (EC) with involved‐field radiation therapy (IFRT), based on 18‐fluorodeoxyglucose positron‐emission tomography. Prognostic factors for overall survival (OS) were analyzed. METHODS: Eligible pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Hideomi, Takenaka, Ryousuke, Okuma, Kae, Ootomo, Kuni, Nakagawa, Keiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129562/ https://www.ncbi.nlm.nih.gov/pubmed/27766787 http://dx.doi.org/10.1111/1759-7714.12369

Ejemplares similares

Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report
por: Katano, Atsuto, et al.
Publicado: (2015)

Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study
por: Yamashita, Hideomi, et al.
Publicado: (2017)

Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy
por: Kobayashi, Reiko, et al.
Publicado: (2016)

Details of recurrence sites after definitive radiation therapy for cervical cancer
por: Kobayashi, Reiko, et al.
Publicado: (2016)

Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia
por: YAMASHITA, MAMI, et al.
Publicado: (2015)

Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma
por: SHIBATA-KOBAYASHI, SHINO, et al.
Publicado: (2013)

Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
por: Yamashita, Hideomi, et al.
Publicado: (2010)

Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis
por: Yamashita, Hideomi, et al.
Publicado: (2017)

A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer
por: Okuma, Kae, et al.
Publicado: (2015)

Four-dimensional measurement of the displacement of metal clips or postoperative surgical staples during 320-multislice computed tomography scanning of gastric cancer
por: Yamashita, Hideomi, et al.
Publicado: (2012)

Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients
por: Yamashita, Hideomi, et al.
Publicado: (2017)

Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report
por: Okuma, Kae, et al.
Publicado: (2011)

Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2021)

Palliative radiotherapy for gross hematuria in patients with advanced cancer
por: Ogita, Mami, et al.
Publicado: (2021)

Adequate target volume in total-body irradiation by intensity-modulated radiation therapy using helical tomotherapy: a simulation study
por: Takenaka, Ryosuke, et al.
Publicado: (2017)

Definitive Radiotherapy for Patients With Anal Squamous Cell Carcinoma: A Retrospective Cohort Study
por: Katano, Atsuto, et al.
Publicado: (2021)

Acceptable fetal dose using flattening filter-free volumetric arc therapy (FFF VMAT) in postoperative chemoradiotherapy of tongue cancer during pregnancy()
por: Takahashi, Wataru, et al.
Publicado: (2019)

Individually wide range of renal motion evaluated by four-dimensional computed tomography
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review
por: Aoki, Shuri, et al.
Publicado: (2020)

Independent absorbed-dose calculation using the Monte Carlo algorithm in volumetric modulated arc therapy
por: Haga, Akihiro, et al.
Publicado: (2014)

National Survey of Radiotherapy Utilization Trends from 2015 to 2019, Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Katano, Atsuto, et al.
Publicado: (2023)

Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomy
por: Potdar, Ankit, et al.
Publicado: (2023)

Intractable Pleural Effusion After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Katano, Atsuto, et al.
Publicado: (2023)

Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study
por: Nakagawa, Keiichi, et al.
Publicado: (2014)

A Case Report of an Early Response to Definitive Chemoradiation for Esophageal Carcinoma Cuniculatum
por: Long, David E., et al.
Publicado: (2020)

Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
por: Jingu, Keiichi, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer
por: Katano, Atsuto, et al.
Publicado: (2022)

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma
por: Du, Qingwu, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
por: Tang, Peng, et al.
Publicado: (2021)

Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
por: Ogita, Mami, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017)

Trimodality Therapy vs Definitive Chemoradiation in Older Adults With Locally Advanced Esophageal Cancer
por: Gaber, Charles E, et al.
Publicado: (2022)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_43bojbr5gs6r154s10kq6vht3k